Empowering Mobility in People With Spinal Cord Injury With a Hands-free, Self-balancing Personal Exoskeleton
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Wandercraft
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Safety of the device for its intended use and user population.
研究概览
简要总结
This study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
详细描述
This personal exoskeleton, developed by Wandercraft as a new version of the Atalante X, offers a novel hands-free and self-balancing design, aiming at enhancing stability and mobility for users in daily activities. The study features an interventional, prospective, single-group, and open-label design, conducted over 2 months at one research facility. A minimum of 5 individuals with spinal cord injury (SCI) and their companions will be included, with the possibility of enrolling up to 10 SCI participants and their 10 respective companions. Over the course of nine to ten scheduled visits, participants undergo a sequence of procedures, beginning with screening and device fitting. This is followed by five training sessions which conclude with an evaluation to issue a competency certificate to confirm the ability to use the device across all its "basic skills". Additionally, two sessions are dedicated to evaluating the exoskeleton's effectiveness outcomes, complemented by an extra practice session. Each visit lasts an average of 1.5 hours.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •User inclusion criteria:
- •Any gender, age 18 years or older
- •Motor complete or incomplete SCI at any level
- •≥ 6 months post SCI
- •Able and willing to attend 9 visits to the center, including sessions of training and assessments of one-to-three hours duration
- •Able to read, understand, and provide informed consent.
- •Patients affiliated to a social security system.
排除标准
- •Diagnosis of neurological injury other than SCI;
- •Progressive condition that would be expected to result in changing neurological status;
- •Severe concurrent medical disease, illness or condition judged to be contraindicated by the site physician;
- •Unhealed or unstable traumatic or high impact lower extremity fracture of any duration that is, in the clinical judgement of the study physician, exclusionary for standing and walking;
- •Individual with history of osteoporotic fracture and / or pathology or treatment causing secondary osteoporosis.
- •Untreatable severe spasticity judged to be contraindicated by the site physician;
- •Untreated/uncontrolled hypertension, as judged to be contraindicated by the site physician;
- •Unresolved orthostatic hypotension (change from baseline seated BP to a fall in 20mmHg SBP and/or fall in 10mmHG DBP and symptoms when standing), or as judged to be contraindicated by the site physician;
- •Open or unhealed skin pressure sores, abrasions, or bruises at any of the contact points of the exoskeleton;
- •Morphological contraindications to the use of the device;
- •Uncorrectable leg length discrepancy over 2 cm (about 0.79 in) when using additional correction tools;
- •Unable to effectively operate the device with a controller, due to functional and/or cognitive impairment, evaluated based on the ability to manipulate the joystick in all direction, press and identify buttons on the controller.
- •Improper fitting in the device;
- •Psychopathology documentation in the medical record that may conflict with study objectives;
- •Pregnancy or women who plan to become pregnant during the study period;
- •Concurrent participation in another interventional trial;
- •Uncontrolled autonomic dysreflexia;
- •Ventilator use at the time of the exoskeleton use.
- •Patient under legal protection.
- •Companion inclusion criteria
- •Any gender, age 18 years or older.
- •Willingness to attend 9 to 10 visits to the center, including sessions of training and assessments of one-to-three hours duration with the SCI user.
- •Able to read, understand and provide informed consent.
- •Companion exclusion criteria:
- •Inability to communicate due to cognitive and language disorders;
- •Any disease, concomitant injury, or condition that interferes with the performance or interpretation of the protocol- specified assessments;
- •Insufficient strength and performance capability, evidenced by the ability to hold and retain the device in case of unbalance/fall;
- •Insufficient availability to complete the study;
- •Concurrent participation in another interventional trial.
研究组 & 干预措施
Hands-free exoskeleton
干预措施: Hands-free exoskeleton (Device)
结局指标
主要结局
Safety of the device for its intended use and user population.
时间窗: Throughout the study and up until the end of Visit 9, after an average of 9 hours of training and 3 hours of assessment.
Collection and analysis of adverse events to evaluate the safety of the device for its intended use and user population, specifically for individuals with spinal cord injury (SCI) performing ambulatory activities hands-free, accompanied by a companion.
次要结局
- Proportion of subjects who complete the Timed Up and Go (TUG) in 3min or less.(After a mean of 7.5 hours of training and a mean of 9 hours of training.)
- Proportion of subjects who complete a distance of at least 40m on the Six-Minute Walk Test (6MWT).(After a mean of 7.5 hours of training and a mean of 9 hours of training.)
- Proportion of subjects who can complete at least 4 out of the 6 Activities of Daily Living (ADLs), in various simulated environments and with the exoskeleton.(After a mean of 7.5 hours of training and a mean of 9 hours of training.)
- Proportion of subjects who complete the 10-Meter Walk Test (10MWT) on indoor surfaces in 1 minute or less.(After a mean of 7.5 hours of training and a mean of 9 hours of training.)
- Proportion of subjects who can don or doff the device within 10 minutes each, separately.(After a mean of 7.5 hours of training and a mean of 9 hours of training.)